Vistra Crecimiento futuro
Future controles de criterios 2/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Vistra de 15.2% y 7.6% por año respectivamente. Se prevé que el BPA crezca en un 19.7% al año. Se espera que la rentabilidad financiera sea de 35% en 3 años.
Información clave
15.2%
Tasa de crecimiento de los beneficios
19.7%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Renewable Energy | 12.7% |
Tasa de crecimiento de los ingresos | 7.6% |
Rentabilidad financiera futura | 35.0% |
Cobertura de analistas | Good |
Última actualización | 22 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Vistra: Too Much Hype Priced In
Nov 22Vistra Corp. (NYSE:VST) Looks Just Right With A 33% Price Jump
Nov 22What Is Vistra Corp.'s (NYSE:VST) Share Price Doing?
Nov 15Vistra: The Nuclear Hype Is Getting Out Of Hand (Rating Downgrade)
Oct 23Nuclear News - Vistra, Constellation Energy, Denison Mines
Oct 09Broken Equilibrium: How Vistra Is Growing Like A Startup
Oct 01Are Investors Undervaluing Vistra Corp. (NYSE:VST) By 42%?
Oct 01Vistra Energy Goes Nuclear
Sep 23Cheap Vistra Stock Is Poised To Exploit Multiple, Strong Trends
Sep 17What You Can Learn From Vistra Corp.'s (NYSE:VST) P/E
Sep 10Vistra Corp.: Essential Holding For Your Growth Portfolio
Aug 14Vistra Corp: Mismatch Of Demand, Supply Promises Bright Future
Jul 14What Is Vistra Corp.'s (NYSE:VST) Share Price Doing?
Jul 13Vistra: This Sector Outperformer Looks Undervalued At This Price
Jun 13Vistra Corp. (NYSE:VST) Looks Just Right With A 45% Price Jump
May 25Here's What To Make Of Vistra's (NYSE:VST) Decelerating Rates Of Return
May 21Third Point - Vistra: In A Pole Position To Capitalize On Trends
May 02Vistra Adds Vital Nuclear Power Capacity
Apr 22Vistra Corp. (NYSE:VST) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected
Apr 04An Intrinsic Calculation For Vistra Corp. (NYSE:VST) Suggests It's 38% Undervalued
Mar 22Earnings Beat: Vistra Corp. (NYSE:VST) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Mar 04Vistra: Shares Go Parabolic, Take Caution Into Earnings
Feb 25Little Excitement Around Vistra Corp.'s (NYSE:VST) Revenues
Feb 07Is It Time To Consider Buying Vistra Corp. (NYSE:VST)?
Jan 17Returns On Capital Are Showing Encouraging Signs At Vistra (NYSE:VST)
Dec 27Vistra Corp.: A Green Transformation With Significant Upside Potential
Dec 17Vistra (NYSE:VST) Has A Somewhat Strained Balance Sheet
Dec 06Vistra: We Believe In The Potential For Strong CAGR The Next 5 Years
Oct 19Is Now An Opportune Moment To Examine Vistra Corp. (NYSE:VST)?
Oct 10Vistra: Regulatory Nightmares Compounded By A Weak Balance Sheet (Rating Downgrade)
Oct 04Vistra (NYSE:VST) Might Have The Makings Of A Multi-Bagger
Sep 22These 4 Measures Indicate That Vistra (NYSE:VST) Is Using Debt Extensively
Sep 01Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 20,577 | 2,761 | 3,910 | 5,731 | 10 |
12/31/2025 | 19,629 | 2,305 | 3,445 | 5,200 | 11 |
12/31/2024 | 17,458 | 1,760 | 2,574 | 4,308 | 7 |
9/30/2024 | 16,265 | 1,852 | 1,312 | 4,091 | N/A |
6/30/2024 | 14,064 | 477 | 1,514 | 3,949 | N/A |
3/31/2024 | 13,408 | 598 | 2,014 | 4,330 | N/A |
12/31/2023 | 14,779 | 1,343 | 3,206 | 5,453 | N/A |
9/30/2023 | 15,570 | 1,281 | 3,050 | 4,965 | N/A |
6/30/2023 | 16,629 | 1,448 | 2,427 | 4,220 | N/A |
3/31/2023 | 15,028 | -393 | -28 | 1,329 | N/A |
12/31/2022 | 13,728 | -1,377 | -844 | 485 | N/A |
9/30/2022 | 13,173 | -388 | -1,218 | 379 | N/A |
6/30/2022 | 11,018 | -1,014 | -1,396 | 128 | N/A |
3/31/2022 | 11,995 | 425 | 138 | 2,038 | N/A |
12/31/2021 | 12,077 | -1,295 | -1,452 | -206 | N/A |
9/30/2021 | 11,287 | -2,029 | -1,156 | 494 | N/A |
6/30/2021 | 11,848 | -1,592 | -750 | 971 | N/A |
3/31/2021 | 11,792 | -1,463 | -484 | 1,132 | N/A |
12/31/2020 | 11,443 | 636 | 1,574 | 3,337 | N/A |
9/30/2020 | 11,779 | 899 | 1,823 | 3,263 | N/A |
6/30/2020 | 11,421 | 569 | 1,808 | 3,163 | N/A |
3/31/2020 | 11,744 | 759 | 1,652 | 2,900 | N/A |
12/31/2019 | 11,809 | 928 | 1,701 | 2,736 | N/A |
9/30/2019 | 11,512 | 508 | 1,560 | 2,431 | N/A |
6/30/2019 | 11,561 | 725 | 1,609 | 2,382 | N/A |
3/31/2019 | 11,302 | 477 | 1,263 | 1,881 | N/A |
12/31/2018 | 9,144 | -54 | 936 | 1,471 | N/A |
9/30/2018 | 7,524 | -447 | 1,002 | 1,404 | N/A |
6/30/2018 | 6,115 | -504 | N/A | 1,024 | N/A |
3/31/2018 | 4,838 | -638 | N/A | 1,223 | N/A |
12/31/2017 | 5,430 | -254 | N/A | 1,386 | N/A |
9/30/2017 | 5,678 | 818 | N/A | 884 | N/A |
6/30/2017 | 5,534 | 731 | N/A | 588 | N/A |
3/31/2017 | 5,472 | 258 | N/A | 175 | N/A |
12/31/2016 | 5,164 | -163 | N/A | -157 | N/A |
9/30/2016 | 5,078 | -2,266 | N/A | -168 | N/A |
6/30/2016 | 5,126 | -3,969 | N/A | 36 | N/A |
3/31/2016 | 5,147 | -3,684 | N/A | 150 | N/A |
12/31/2015 | 5,370 | -4,677 | N/A | 237 | N/A |
9/30/2015 | 5,512 | -8,134 | N/A | 268 | N/A |
6/30/2015 | 5,581 | -6,653 | N/A | 274 | N/A |
3/31/2015 | 5,733 | -7,022 | N/A | 637 | N/A |
12/31/2014 | 5,978 | -6,229 | N/A | 444 | N/A |
9/30/2014 | 6,058 | -2,680 | N/A | 235 | N/A |
6/30/2014 | 6,144 | -2,584 | N/A | 101 | N/A |
3/31/2014 | 6,156 | -2,216 | N/A | -554 | N/A |
12/31/2013 | 5,899 | -2,197 | N/A | -270 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (15.2% al año) de VST es superior a la tasa de ahorro (2.6%).
Beneficios vs. Mercado: Se prevé que los beneficios (15.2% al año) de VST crezcan menos que el mercado US (15.4% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de VST crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (7.6% al año) de VST crezcan más despacio que el mercado de US (8.9% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 7.6% al año) de VST crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de VST sea alta dentro de 3 años (35%)